Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastases

Postapproval trials and patient registries have their pros and cons in the generation of postapproval data. No direct comparison between clinical outcomes of these data sources currently exists for advanced melanoma patients. We aimed to investigate whether a patient registry can complement or even...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismail, Rawa K., Sikkes, Nienke O., Wouters, Michel W.J.M., Hilarius, Doranne L., Pasmooij, Anna M.G., van den Eertwegh, Alfonsus J.M., Aarts, Maureen J.B., van den Berkmortel, Franchette W.P.J., Boers-Sonderen, Marye J., de Groot, Jan Willem B., Haanen, John B.A.G., Hospers, Geke A.P., Kapiteijn, Ellen, Piersma, Djura, van Rijn, Roos S., Suijkerbuijk, Karijn P.M., ten Tije, Bert-Jan, van der Veldt, Astrid A.M., Vreugdenhil, Art, van Dartel, Maaike, de Boer, Anthonius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Articles: Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757745/
https://www.ncbi.nlm.nih.gov/pubmed/33351553
http://dx.doi.org/10.1097/CMR.0000000000000707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757745/
https://www.ncbi.nlm.nih.gov/pubmed/33351553
http://dx.doi.org/10.1097/CMR.0000000000000707

Ejemplares similares